|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Provision for credit losses | |||||
| Impairment of intangible assets | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Gain on sale of ENTADFI® assets | |||||
| Operating loss | |||||
| Non-operating income (expenses): | |||||
| Interest expense | |||||
| Change in fair value of derivative liabilities | |||||
| Gain on extinguishment of debt | |||||
| Change in fair value of equity securities | |||||
| Other income, net | |||||
| Total non-operating income | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Net loss from discontinued operations, net of taxes | |||||
| Net loss | |||||
| Net loss from continuing operations per basic and diluted common shares outstanding (in dollars per share) | |||||
| Net loss from discontinued operations per basic and diluted common shares outstanding (in dollars per share) | |||||
| Net loss per basic and diluted common shares outstanding (in dollars per share) | |||||
| Basic and diluted weighted average common shares outstanding (in shares) | |||||
| Net loss per diluted common share outstanding | |||||
| Diluted weighted average common shares outstanding |
Loading...